A 'partial' rodent model for schizophrenia has been used to characterize the regulation of hippocampal genes in response to amygdalar activation. At 96 h after the administration of picrotoxin into the basolateral nucleus, we have observed an increase in the expression of genes associated with 18 different monoamine (ie adrenergic alpha 1, alpha 2 and beta 2, serotonergic 5HT5b and 5HT6, dopamine D4 and muscarinic m1, m2 and m3) and peptide (CCK A and B, angiotensin 1A, mu and kappa opiate, FSH, TSH, LH, GNRH, and neuropeptide Y) Gprotein coupled receptors (GPCRs). These latter receptors are associated with three different G protein signaling pathways (Gq, Gs, and Gi) in which significant changes in gene expression were also noted for adenylate cyclase (AC4), phosphodiesterase (PDE4D), protein kinase A (PKA), and protein kinase C (PKC). Quantitative RT-PCR was used to validate the results and demonstrated that there were predictable increases of three GPCRs selected for this analysis, including the dopamine D4, alpha 1b, and CCK-B receptors. Eight out of the nine monoamine receptors showing these changes have moderate to high affinity for the atypical antipsychotic, clozapine. Taken together, these results suggest that amygdalar activation may play a role in the pathophysiology and treatment of psychosis by regulating the activity of multiple GPCR and metabolic pathways in hippocampal cells. Molecular Psychiatry (2004) 9, 932-945.
The amygdala plays a central role in emotional responses and the encoding of context-dependent explicit memory by the hippocampus. 1 There is growing interest in the possibility that the amygdala and hippocampus may contribute to the pathophysiology of psychotic disorders. 2, 3 Postmortem studies in which a variety of approaches have been employed have presented evidence for a defect of GABAergic function in schizophrenia [4] [5] [6] [7] and, more recently, bipolar disorder. 3, 8, 9 Using quantitative microscopic approaches, diminished GABA cell function has been repeatedly observed in sectors CA3 and CA2 of hippocampus of subjects with schizophrenia and bipolar disorder (for a review see Benes 3 ). Interestingly, anterograde tracing studies have demonstrated that both of these sectors receive abundant projections from the basolateral nucleus of the amygdala 10, 11 where a decrease of GABAergic function is also believed to coincide. 12 Based on these observations, it has been postulated that an increased outflow of excitatory activity from the amygdala may play a role in the induction of GABAergic abnormalities in the hippocampus. To explore this possibility further, we have developed a 'partial' rodent model in which a low, nonepileptogenic dose of picrotoxin, a noncompetitive antagonist of the GABA A receptor, is infused into the basolateral nucleus to diminish GABAergic activity and increase the flow of excitatory activity to the hippocampal formation. Using this paradigm, it has been possible to induce changes in GABA cells that are remarkably similar to those reported in postmortem microscopic analyses of the hippocampus in postmortem studies of schizophrenia and bipolar disorder. 13, 14 Neuropsychiatric disorders pose a unique challenge to the field of neuroscience when the regulation of genes associated with complex neural circuitry, like that found in the limbic lobe, are the targets for investigation. The 'partial' rodent model described above has significantly contributed to our understanding of how the activation of amygdalar projections may alter the regulation of hippocampal neurons. Since a discrete experimental manipulation of this type is only capable of inducing relatively subtle changes in the expression of genes within particular subregions, sublaminae and/or cellular subtypes of the hippocampus, novel approaches to the analysis of such data are greatly needed to improve the sensitivity of gene expression profiling. Although the microarray approach has the strength of providing information about thousands of genes, relatively small changes in response to functional alterations of a complex circuit often fall below the level of detection when conventional statistical approaches are employed. To overcome this pitfall, we have developed a novel post hoc statistical approach to analyze gene expression profiling data within the context of the specific biopathways and/or clusters available through GenMapp (www.genmapp.org). In the study described below, we have applied this approach to the analysis of gene expression profiling in the hippocampus of rats receiving picrotoxin infusion in the basolateral amygdala. To our knowledge, this is the first instance in which a microarray approach has been used to study changes in the genetic regulation of specific signaling pathways that occur in response to an experimental manipulation of a complex circuit like the amygdalohippocampal pathway.
Methods

Surgical and experimental procedures
In total, 20 adult (300 g) Sprague-Dawley male rats, were anesthetized (100 mg/kg ketamine; 40 mg/kg xylazine) and placed in a stereotaxic device (Stoelting, Wood Dale, IL, USA). A burrhole was drilled into the skull and a Hamilton syringe (1.0 ml) was used to infuse picrotoxin (n ¼ 10; 50 ng/0.8 ml; RBI, Natick, MA, USA) or vehicle (n ¼ 10; 0.8 ml saline) in the BLn (A 5.3, L 5.0, H 1.6, interaural 15 ). A slow rate (0.8 ml over 50 min, continuous infusion) was used for both picrotoxin and vehicle. As previously described, 16, 17 the use of local infusion of a GABA A antagonist into the amygdala to alter amygdalar activity elicits an increase of discharge activity in local neurons without activation of fibers en passant. 18 A strength of this activation paradigm is that it relies on endogenous excitatory activity induced by blockade of an intrinsic inhibitory mechanism. Although diffusion of picrotoxin to other regions surrounding the deep nuclei of the amygdala could have potentially influenced the results reported below, previous studies have suggested that picrotoxin does not show widespread diffusion beyond a local infusion site. 16 In a preliminary series of experiments, acute picrotoxin administration was followed by killing at 2, 13 24 , and 96 h 14 after drug administration in the basolateral nucleus. These timepoints were associated with decreases, no change, and increases of GAD 65 and GAD 67 expression at 2, 24, and 96 h, respectively. In designing the current experiment, the 2 h time point would have been too early for the detection of significant changes in the expression of genes other than immediate-early genes (IEGs). On the other hand, at 24 h, early acute changes may have returned to baseline, whereas at 96 h the preliminary immunocytochemical studies demonstrated extensive changes in the amount of protein associated with various markers for the GABA system.
After medicating the surgical wound, the rats were placed in their home cages and killed 96 h later. The brains were promptly removed, the hippocampal formation ipsilateral to the injected amygdalae were dissected whole, frozen on dry ice and stored at À701C in microcentrifuge tubes until RNA extraction. During the survival period, the animals were periodically monitored for behavioral effects and/or seizure activity. None were detected and no difference was noticed between vehicle-and picrotoxin-treated rats. All procedures were approved by an IACUC Committee at McLean Hospital (Protocol Number 00-11/2-14) and were in compliance with principles expressed in the National Institute of Health, United States Public Health Service Guide for the Care and Use of Laboratory Animals.
Preparation of RNA extracts
Total RNA extracts were obtained using the Totally RNA Kit from Ambion, Inc. (Austin, TX, USA). Whole frozen hippocampi from each animal were homogenized (PowerGen 125, Fisher Scientific) in denaturation/lysis solution containing guanidinium thiocyanate and cationic detergents. The RNA was then recovered from each lysate in a two-step organic extraction. First, the lysate was mixed with an equal volume of phenol : chloroform : isoamyl alcohol, vortexed, chilled, and centrifuged at 12 000 g. The resulting aqueous layer was transferred to a new tube, 1/10th the volume of sodium acetate was added and the solution mixed vigorously. An equal volume of acid-phenol : chloroform was then added and the solution was vortexed, chilled, and centrifuged at 12 000 g. The resulting second aqueous phase was then drawn off and an equal volume of isopropanol was added. This preparation was stored at À201C for 1 h followed by centrifugation at 12 000 g for 20 min at 41C. The supernatant was aspirated off and the RNA pellets were resuspended in RNase-free dH 2 O/0.1 mM EDTA. To ensure the highest quality total RNA preparation, the extracts were processed further with a clean-up step involving passage over a Qiagen RNeasy mini column (Qiagen, Valencia, CA, USA), followed by series of ethanol/proprietary buffer washes. Enriched RNA was then eluted from the columns in RNase-free dH 2 O and stored at À701C. The quality of the RNA was assessed using an Agilent Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA, USA) to obtain 28S/18S ribosomal RNA ratios for each extract. Total RNA yield was determined from optical density readings at 260 nm with a SpectraMax Plus spectrophotometer (Molecular Devices, Sunnyvale, CA, USA).
Gene expression profiling
Biotinylated target RNA was prepared from the total RNA extracts of each animal according to the recommended Affymetrix Protocols (flowchart at http://www.affymetrix.com/support/technical/data-sheets/t7_datasheet.pdf). A measure of 8 mg total RNA was used for cDNA synthesis with a SuperScript II double-stranded cDNA synthesis kit (Invitrogen, Carlsbad, CA, USA). The SuperScript II kit employs a standard two-step reverse transcription reaction to generate cDNA complimentary to target mRNA. In vitro transcription of biotinylated RNA (bRNA) was performed with an Enzo-IVT kit (Affymetrix, Santa Clara, CA, USA), which utilizes T7 RNA polymerase to produce a linear amplification of target cDNA generated during the previous reverse transcription step. Target bRNA from each animal was then fragmented and individually hybridized to the RG-U34A array (Affymetrix) overnight in a 'rotisserie oven' at 451C. The microarrays were then stained on the Affymetrics fluidics station with two rounds of streptavidin-phycoerythrin (Molecular Probes, Eugene, OR, USA) and one round of biotinylated antistreptavidin antibody (Vector Labs, Burlingame, CA, USA). The microarrays were then scanned twice and visually inspected for evidence of artifacts, including 'edge' effects, bright spots, or blemishes, that might have led to aberrant readings for genes located on those portions of the chips. The Affymetrix MicroArray Suite 5.0 Software (Affymetrix) was used to control the scanner, average the two images, define the probe cells and compute an intensity value for each cell. The data for each probe set (ie consisting of Perfect Match (PM) and Mismatch (MM) probe cells for a given gene) were evaluated. Based on matchmismatch values for each probe pair, a Discrimination Score, R (R ¼ PMÀMM/PM þ MM) was determined for each probe pair and 'present' and 'absent' calls were assigned to each probe set based on previously established Detection P-values, alpha 1 (eg P ¼ 0.04) and alpha 2 (eg P ¼ 0.06), respectively. As shown in Table 1 , the number of 'present' calls varied between 36.8 and 45.6%, while the average 3 0 -5 0 ratio was approximately 1.3. In addition, the expression values for the 'housekeeping' genes, glyceraldehyde-3-phosphate dehydrogenase (G3PDH) and b-actin, were separately evaluated in both the saline-and picrotreated groups. The mean7the standard error were found to be virtually identical for the two genes in both groups, providing support for the assumption that the linear amplification of mRNA was consistent across experimental and control tissue extracts. Furthermore, in QRT-PCR experiments, the endogenous control G3PDH was not significantly changed between the two groups, indicating uniform amplification of target mRNA in that portion of our study as well (see below).
Data analyses
General considerations To analyze the microarray data, the Affymetrix Data Mining Tool Version 3.0. (DMT 3.0) and the DNA Chip Analyzer (dChip) software package 20 were both used to evaluate the quality of the chip data by assessing the expression indices for each probe array. The dChip program provided a statistical method for reducing errors due The data shown were obtained from Affymetrix RU-34A rat genome chips that were run for each of 10 saline-and 10 picrotoxin-treated rats. The RNA extracts for each of the rats were hybridized and analyzed randomly to avoid a sequencing bias. The noise, background, % P (Present) Calls and 3 0 /5 0 ratios are listed for each of the 20 microarrays that were run. The average value for each variable is shown at the bottom of the respective lists.
to nonspecific cross-hybridizing probes and image contamination 20 and generally yielded more robust findings when the Perfect Match Model (PM) was used.
Biopathway/cluster analyses: In order to identify biologically relevant clusters of inter-related genes, GenMapp algorithms (www.genmapp.org) were used to relate the dChip findings to several different biochemical pathways and/or biologically related clusters of genes. The general strategy for the analyses involved the establishment of both low and high stringency levels for inclusion of individual genes in the GenMapp analyses (see below). Generally, the fold changes were predictably small (rangeD1.05-1.32), whereas the P-values were generally larger than 0.05. The first stage of the analysis involved selecting genes according to high and low stringency criteria for inclusion in the GenMapp biopathways analysis. The high stringency criterion was set at P ¼ 0.05. For the low stringency criterion, the inclusionary P-value was increased progressively to 0.1 and 0.25, respectively. When P ¼ 0.1, the numbers of genes included in the GenMapp pathway analysis showed a discernible increase which occurred almost exclusively in those pathways previously showing substantial activations when the p was set at 0.05. When the inclusionary criterion was increased to P ¼ 0.25, further increases in the number of genes showing altered expression in the GenMapp pathways were observed. However, in contrast to the situation that was observed with P ¼ 0.05 or P ¼ 0.1, some of the GenMapp pathways that previously had not shown any activation now showed a random scatter of a small number of genes when the P-value was set at 0.25. This latter observation suggested that further increases of the Pvalue would likely increase the background and compromise the signal-to-noise ratio of the post hoc analysis.
In order to assess the statistical significance of changes in gene expression in specific GenMapp biopathways/clusters, an ad hoc statistic was developed based on a combination of probability theory and two separate corrections for multiple comparisons. A requirement for such an analysis is that changes in the hybridization of any particular gene to its probe sets must occur independently of probe sets for other genes. If the probe sets for all of the genes in one particular biopathways were all clustered within a discrete sector of a microarray, then the hybridization of the respective mRNAs to their appropriate probe sets could not be assumed to be independent of one another and probability theory could not be used for the analysis. The Affymetrix RG-U34A microarrays employed in this study were tiled with nondispersed probe sets, such that all 16-20 probe pairs representing a particular gene sequence were positioned together. We considered whether the probe sets for several different genes associated with one particular biopathway might be similarly clustered together in one region of the chip and, if so, whether an artifact induced during processing could cause several clustered genes to show changes in expression that are dependent upon chip position. This hypothetical situation would be unlikely to occur, however, since the Perfect Match/Mismatch (PM/MM) ratio generated by the Affymetrix system must show a detectable signal (PM) over background (MM) in order for significant changes in expression to be detected. If a chip artifact were to influence the hybridization of RNA to the probes or perhaps the fluorescent emissions emanating from the probes, it would be difficult to observe significant changes in expression because the PM/MM ratio would tend to not show a detectable signal over background for the genes in the cluster. In practice, when small disruptions in the expression profiles on a single region of the chip are observed, this portion of the chip is demarcated and excluded from the analysis, that is, if all other quality control parameters are acceptable for that chip. In our experience, when such chip defects do occur, they have not shown any apparent clustering of genes according to biopathways or function. Finally, visual inspection of microarrays for the location of single genes represented within a particular GenMapp pathway has demonstrated a broad degree of scatter, even when only the genes showing changes in expression are individually inspected. Based on these various considerations, we have concluded that the arrangement of the probe sets for the genes on the Affymetrix RG-U34A microarrays are sufficiently independent of one another to justify the post hoc analysis based on probability theory.
In using the post hoc approach, a composite probability, P c, for each of the respective pathways was computed by multiplying the individual P-values for each gene meeting high or low stringency criteria (ie P 1 , P 2 yP i ). This number was divided by the ratio of the number of genes meeting high or low stringency criteria (n i ) and the number of genes potentially showing significant changes (n t ) in each pathway. The total number of GenMapp pathways examined (N p ) was also used to correct for multiple comparisons. The following equation expresses these relationships,
This equation provided two separate corrections for multiple comparisons by multiplying by both N p and n t . The a-level of significance for each GenMapp biopathway or cluster was established by examining the distribution of genes that met criteria for inclusion in the analysis and the final P ¼ value obtained with the equation described above. Most GenMapp pathways showed one or no genes meeting the stringency criteria and the P-values tended to be greater than 5 Â 10
À4
. A minority, however, showed two or more genes meeting the stringency criteria for inclusion and the resulting P-value tended to be less than 5 Â 10
. By visually comparing the pathways according to the number of genes showing changes in regulation and the resulting post hoc P-values, it was apparent that those with a post hoc P ¼ 5 Â 10 À4 appeared to show a significant amount of change and this number was chosen as the a-level for these post hoc analyses.
FRET-based quantitative RT-PCR In order to quantitate the amount of RNA associated with various target genes, a fluorescence resonance emission energy transfer (FRET) approach to RT-PCR was employed. Total RNA used for QRT-PCR was obtained from RNA used in the microarray analysis (see above) for both saline controls (n ¼ 7) and 96 h picrotoxin-treated animals (n ¼ 7). First-strand cDNA was synthesized from 1 mg of total RNA using Superscript II reverse transcriptase and oligo-dT primers (Invitrogen). The 20 ml reaction volume was diluted five-fold for use in the PCR. Based on the expression profiles obtained in the microarray analysis, five genes were selected for QRT-PCR: glutamic acid decarboxylase (GAD 65 ) (M72422), GAD 67 (M76177), cholecystokinin receptor B (CCKB-R) (X79208), Dopamine receptor D4 (RATD4) (M84009) and a-1B adrenergic receptor (Alpha1B) (M60655).
Primer pairs and dual-labeled hybridization probes were designed using web-based applications Primer3 (www.genome.wi.mit.edu) and the Oligo Toolkit (Integrated DNA Technologies). The sequence information for each of the primer pairs (ie forward and reverse) and the dual-labeled hybridization probes is shown in Table 2 . The PCR amplifications were performed on a Smartcycler (Cepheid, Sunnyvale, CA, USA)) using Platinum Quantitative PCR Supermix-UDG (Invitrogen) with 300 nM primers and 150 nM fluorogenic probe. For the signal detection, the Smartcycler was programmed to an initial step of 2 min at 501C and 2 min at 951C, followed by 45 thermal cycles of 15 s at 951C and 1 min at 601C. The threshold cycle C t , which correlates inversely with the target mRNA levels, was measured as the cycle number at which the reporter fluorescent emission increased significantly above a pre-set threshold level. Relative standard curve methods were used to determine the transcript levels for all genes. Standard curves for all gene targets and constitutively expressed 'house-keeping gene' GAPDH were constructed using serial dilutions of cDNA amplicons amplified from control templates. Differences in the total amount of RNA present in each target sample were normalized with respect to the reference gene using a relative expression software tool (REST) for group-wise comparison of the resulting expression ratios. 21 
Results
When the gene expression profiling data were analyzed in relation to several different GenMapp The sequences shown represent primer pairs and dual-labeled hybridization probes that were designed using web-based applications (www.genome.wi.mit.edu) and the Oligo Toolkit from Integrated DNA Technologies. The numbers in parentheses are the Genbank accession numbers for each gene. The number of base pairs associated with each primer is shown in the right column. For the target genes, tetrachlorofluorescein (TET) was used as the reporter and 6-TAMT as the 'quencher.' For the 'housekeeping' gene GAPDH, Texas Red was used as the 'recorder' and Black Hole Quencher (BHQ-2) were used because they have spectral properties that are different from those for TET and 6-TAMT and this made it possible to run a duplex assay in which both a target and reference gene were analyzed in the same tube. (Table 3) , both low and high stringency criteria (P ¼ 0. 25 and 0.05, respectively) for entry of a gene into the analysis were compared alone and in combination. For the composite P c , the a level was set at 1.0 Â 10
À4
. Generally speaking, the genes that met the high stringency criterion tended to discriminate the same GenMapp pathways and/or clusters as the genes satisfying the low stringency criterion (Figures 1-3) . These included the monoamine (ie m1, m2, m3, 5HT5b, 5HT6, alpha 1b, alpha 2a, beta2, and D4) and peptide (ie angiotensin AT 1A -R and ATR, CCK A , CCK B , neuropeptide Y, the kappa KOR-1, and mu, MOR-1 opioid receptors) G proteincoupled pathways (Figures 1 and 2, respectively) . As shown in Figure 3 , the G protein clusters in GenMapp also showed several subunits and/or isoforms of Gproteins or associated enzymes (e.g., adenylate cyclase and phosphodiesterase) and proteins (e.g., kRAS b and the epsilon isoform of protein kinase C) that met either the high or low stringency criteria. Other maps that showed clusters of genes meeting criteria for inclusion in the post hoc analysis included the electron transport chain (i.e., subunits of Complex I and IV, as well as Complex V (ATP synthase), mitochondrial fatty acid beta oxidation and fatty acid degradation (i.e., lipoprotein lipase, long-chain fatty acid CoA ligases 5 and 6, and carnitine-O-palmitoyltransferase I) pathways, translation factors and the TGFb signaling pathway. As shown in Table 4 The data shown are organized according to several different biopathways/clusters appropriate to studies in rat brain available from GenMapp (www.genmapp.org). The individual genes represented for each pathway are listed according to fold changes, P-values for significance and direction of change. All the genes shown satisfied either a high (P ¼ 0.05) or low (P ¼ 0.25) stringency criterion for inclusion in the post hoc analysis of bio-pathways and clusters. eicosanoid biosynthesis, Wnt signaling and apoptosis showed some genes satisfying low or high criteria, but these pathways/clusters did not attain significance as designated for this post hoc analysis.
In order to validate the microarray analyses, quantitative PCR using a highly sensitive and reproducible fluorescence resonance energy transfer (FRET)-based approach was applied to a subset of Figure 1 A GenMapp diagram depicting changes in the regulation of various subtypes of monoamine receptors using low stringency criteria. The serotonin receptors 5HT5b and 5HT6, the adrenergic receptors alpha 1b, alpha 2a, and beta 2, and the cholinergic muscarinic receptors M1, M2 and M3 all showed an upregulation. Although the dopamine D1 and D2 receptors did not show a change in regulation in the picrotoxin-treated rats, the D4 receptor gene was upregulated. Although these receptors only satisfied low stringency criteria, the post hoc test of significance demonstrated P ¼ 4.9 Â 10 À6 . genes. Quantitative estimates of mRNA expression in hippocampus isolated from saline-and picrotoxintreated rats ( Figure 4) were normalized with respect to GAPDH mRNA that served as an internal standard for each of the target gene assays ( Figure 5) . A bivariate analysis of log concentrations vs threshold cycle for dopamine D4 mRNA showed a striking degree of linearity (Figure 4 , inset) and the FRET-based QRT-PCR assay showed good separation of the data for the picrotoxin vs vehicle-treated animals ( Figure 4) . A similar degree of linearity was seen for the other target genes. The target genes examined included the GAD 65 , GAD 67 , the dopamine D4, adrenergic alpha 1B, and CCK-B receptors because these met criteria for inclusion in the post hoc analysis. As shown in Figure 5 , increases in mRNA encoding the dopamine D4 and adrenergic alpha 1b receptors (fold changes ¼ 2.7 and 2.3, respectively) were found to be quite significant using the REST analysis. Although the direction of change in the mRNA levels of these genes are consistent with the microarray data, the magnitude of the upregulation is much higher, probably reflecting the increased sensitivity of FRETbased QRT-PCR when compared to microarray-based gene expression profiling. Additionally, the mRNA encoding the CCKR-B gene was also found to be upregulated by a factor of 1.9 in the picrotoxin-treated animals, but the REST analysis indicated that this change was not significant.
Discussion
The results of this study demonstrate that picrotoxin infusion in the basolateral nucleus of the amygdala is capable of inducing significant changes in gene The composite probability, 65 and GAD 67 -containing terminals in the hippocampus of picrotoxin-treated rats, 14 very pronounced increases of GAD65 and GAD67 were also noted when FRET-based qRT-PCR was used and these results correspond well with those described above.
14 GABAergic cells in the hippocampus account for only 10% of the total neuronal population in this region 22 and the amount of mRNA expressed by GABAergic cells could fall below the level of detection needed for the microarray technique employed here. RT-PCR, on the other hand, with its high degree of sensitivity, was able to detect increases of GAD 67 and GAD 65 mRNA, despite the fact that GABA cells account for only 10% of the total number of hippocampal neurons. 22 Since there were approximately 8000 genes represented on the Affymetrix RG- 67 , the adrenergic alpha 1b, the dopamine D4 receptor and the CCKb receptor. The data were normalized with respect to the 'housekeeping' gene, glyceraldehydes-3-phosphate dehydrogenase (GAPDH) that did not show any difference in regulation in the picrotoxin-treated rats as compared to the saline-treated controls, suggesting that is constitutively expressed under the conditions employed in these experiments. The threshold cycle (C t ) values for GAPDH are shown separately for the salineand picrotoxin-treated groups for each of the target genes.
U34A chip, there may have been many genes showing no apparent changes in expression when conventional statistical approaches are employed. Indeed, when a novel approach in which Gen Mapp pathways and a post hoc statistic that takes into account these pathways were employed, meaningful changes in biologically relevant clusters of genes have been detected. Accordingly, the data obtained in this study have provided some novel insights into how the basolateral amygdala may influence the regulation of complex signaling and metabolic pathways in the hippocampus.
G protein-coupled pathways
An important general area where changes in gene expression met criteria for inclusion in the post hoc analysis of GenMapp biopathways/clusters was related to monoamine and peptide G protein-coupled receptors. Overall, there were 14 peptides that met criteria set for the post hoc analysis. The CCK receptors are particularly interesting because they have been associated with increases of GABA release. 23, 24 This latter mechanism may be mediated by protein kinase C 25 for which a significant decrease in mRNA expression was detected in the current study. Given that the two markers showed changes in the opposite direction, it is unclear as to whether these two findings are linked with one another or may perhaps represent changes in different cell populations or hippocampal sectors. Either way, a decrease of CCK mRNA 25 and binding sites 26 have been reported in postmortem studies of schizophrenia and this peptide is believed to play a role in both the pathophysiology 27, 28 to generate ATP and possibly even its treatment. 29 Interestingly, CCK-immunoreactive terminals were found to be increased in the hippocampus following picrotoxin infusion in the amygdala. 14 Mu opioid receptors were also upregulated in the picrotoxin-treated rats and this too is potentially an important finding because this peptide is thought to disinhibit pyramidal neurons in the hippocampus, possibly via neuropeptide Y-containing interneurons. 30 Interestingly, we have also observed an upregulation of neuropeptide Y receptors in the picrotoxin-treated rats and these latter binding sites may play a neuroprotective role against excitotoxicity in the hippocampus. 31 In Figure 6 , there are nine upregulated monoamine receptors associated with three different G proteins pathways. These pathways include:
(a) m1, m3, 32,33 a1 and a2 34 receptors possibly associated with Gq and protein kinase C; The second and third pathways are both cyclic AMP dependent and ultimately utilize protein kinase A as an intermediate signal in mechanisms that regulate the occurrence of long-term potentiation (LTP). 38 In the current study, both adenylate cyclase (AC4) and phosphodiesterase (PDE4) were upregulated, making it possible that the synthesis and breakdown of cyc-AMP could potentially have attained a steady-state condition. It is not clear, however, whether these changes occurred in the same cell types and/or hippocampal subregions or in separate tissue compartments. The upregulation of multiple monoamine receptors could theoretically increase the overall activity of this pathway with the potential for a facilitation of long-term potentiation (LTP) in the rats receiving picrotoxin. The PKA and PKC pathways have both been found to have antiapoptotic potential, particularly when the epsilon isoform of PKC is expressed. 39 This is noteworthy because a recent study has presented evidence for a reduction of apoptotic potential in schizophrenia. 40 
Functional implications
The influence of the amygdala on the hippocampal formation involves complex interactions, ones that are believed to contribute to both associative 41 and episodic 42 memory, as well as prepulse inhibition of the startle reflex. 43. Some believe that the functional interconnections between the amygdala and hippocampus may actually involve a 'double dissociation' between the fear conditioning that occurs in relation to explicit and contextual cues, respectively. 44 The activity of this complex circuitry and the behaviors that are modulated by it appear to be regulated, at least in part, by a combination of serotonergic, noradrenergic 45, 46 and, in primates and man, dopaminergic mechanisms. 47 The interactions among these neuromodulatory systems may also be important. For example, the cholinergic system, which is also believed to play a critical role in learning and memory, 48, 49 may interact with the serotonergic system in the regulation of cognitive behaviors, such as spatial learning. 50 An important aspect of the data reported here is the fact that there was an upregulation of nine different monoaminergic receptors, including the m 1 , m 2 , and m 3 muscarinic, 51 a 1 , 52 a 2 and b 2 adrenergic, 53 serotonin 5HT 5b and 5HT 6 54,55 and dopamine D 4 56 receptors in the hippocampus of picrotoxin-treated rats. With the exception of the 5HT 5b receptor, all have moderate to high affinity for the atypical antipsychotic drug clozapine. It has been difficult to explain why a drug that shows such a marked degree of nonselectivity would prove to be the most effective antipsychotic drug available for the treatment of schizophrenia. 57 Based on the current results, it is tempting to speculate that the unique efficacy of clozapine may be related to its ability to simultaneously block multiple monoaminergic receptors that are upregulated in the hippocampus in response to amygdalar stimulation. All of these receptors appear to be associated with G-coupled protein pathways and involve pivotal components to intracellular signaling. The latter include adenylate cyclase, 58, 59 protein kinase C 60, 39 and RAS 61, 62 that can theoretically influence the occurrence of LTP 63, 64 and/or apoptosis. 65, 59 In adipose tissue, both PKC 66 and PKA 67 have been implicated in the regulation of lipoprotein lipase via beta-adrenergic receptors. 68 In addition to a downregulation of lipoprotein lipase (LPL), several other genes associated with fatty acid oxidation and the electron transport chain met criteria for inclusion in the post hoc analysis and both of these latter pathways showed significant differences in the picrotoxin-treated group (see Table 4 ). Stimulation of beta-adrenergic receptors in adipose tissue 69 or liver 70 is associated with a decreased transcription of LPL. In the context of the current report, the upregulation of the beta receptor is compatible with the downregulation of LPL. Thus, it is theoretically possible that the changes in the monoamine GPCRs detected in this study may interplay with other alterations found in the fatty acid oxidation pathways. The latter could, in turn, bear some relationship to the downregulation of the electron transport chain and the absence of significant changes in apoptotic cascades that were also observed in picrotoxin-treated rats.
Conclusions
The current report provides evidence suggesting that acute stimulation of the hippocampus by the amygdala is capable of inducing changes in the expression of genes associated with multiple intracellular and metabolic pathways. Taken together, the current findings suggest that activation of G protein-coupled pathways associated with the cholinergic, adrenergic, serotonergic and dopaminergic systems 71 may play a central role in the metabolic responses of hippocampal neurons to amygdalar stimulation.
